1. Home
  2. ABCL vs KNF Comparison

ABCL vs KNF Comparison

Compare ABCL & KNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.66

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Knife Riv Holding Co.

KNF

Knife Riv Holding Co.

N/A

Current Price

$49.66

Market Cap

3.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
KNF
Founded
2012
1917
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
ABCL
KNF
Price
$9.66
$49.66
Analyst Decision
Strong Buy
Buy
Analyst Count
14
9
Target Price
$18.69
★ $69.80
AVG Volume (30 Days)
★ 2.8M
637.4K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 10.91
N/A
EPS
N/A
★ 1.81
Revenue
$75,128,000.00
★ $3,146,012,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
$13.74
$3.05
P/E Ratio
★ N/A
$28.34
Revenue Growth
★ 160.56
8.52
52 Week Low
$2.75
$47.79
52 Week High
$14.98
$96.28

Technical Indicators

Market Signals
Indicator
ABCL
KNF
Relative Strength Index (RSI) 34.01 36.90
Support Level $3.45 $48.47
Resistance Level $12.91 $63.49
Average True Range (ATR) 0.84 2.96
MACD -0.22 -0.87
Stochastic Oscillator 2.41 1.23

Price Performance

Historical Comparison
ABCL
KNF

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About KNF Knife Riv Holding Co.

Knife River Corp is a people-first construction materials and contracting services company. It provides construction materials and contracting services to build safe roads, bridges, airport runways, and other critical infrastructure needs that connect people. The group is a provider of crushed stone, sand, and gravel in the United States. It operates through four reportable segments: West, Mountain, Central, and Energy Services.

Share on Social Networks: